ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

TRX Tissue Regenix Group Plc

61.50
0.50 (0.82%)
09 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tissue Regenix Group Plc LSE:TRX London Ordinary Share GB00BNTXR104 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 0.82% 61.50 61.00 62.00 61.50 61.50 61.50 18,448 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 29.49M -302k -0.0043 -143.02 43.4M
Tissue Regenix Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker TRX. The last closing price for Tissue Regenix was 61p. Over the last year, Tissue Regenix shares have traded in a share price range of 49.00p to 71.50p.

Tissue Regenix currently has 70,574,468 shares in issue. The market capitalisation of Tissue Regenix is £43.40 million. Tissue Regenix has a price to earnings ratio (PE ratio) of -143.02.

Tissue Regenix Share Discussion Threads

Showing 8176 to 8195 of 14750 messages
Chat Pages: Latest  338  337  336  335  334  333  332  331  330  329  328  327  Older
DateSubjectAuthorDiscuss
09/3/2015
18:49
Cheers Ray.
Welcome temmujin.

500,000 late trade showing, not sure when from.

The other states should follow with the Medicare approval in due course.

I hope we'll be getting ongoing reports from the US of progress with the Stage IV Clinical Trial.

bamboo2
09/3/2015
17:49
Yes bamboo, saw the rns. Quite a wait? I'm a patient man.😉
rayrac
09/3/2015
16:57
09 March 2015

Tissue Regenix Group plc

Notice of Preliminary Results

YORK, 9(th) March 2015 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix"), the regenerative medical devices company, announces that it will publish its unaudited preliminary results for the year ended 31 January 2015, on Monday 11(th) May 2015.

bamboo2
06/3/2015
12:24
Had another little top up today.
luminoso
06/3/2015
10:09
i'm in !..looks way under valued
temmujin
06/3/2015
08:28
Brill news ! Nice of them to release the teaser yesterday then the biggie today.
igbertsponk
06/3/2015
08:19
Look what happened at BTG! That's based to a great extent on varicose vein treatment.

TRX have, in my opinion, a much bigger market?

rayrac
06/3/2015
08:17
Great news, sounds like more to come as well....
bobsgonnamakemerich
06/3/2015
08:08
It's not on everyone's radar just yet. Give it time!!
rayrac
06/3/2015
08:06
Cheers Ray, quite a few early buys, we haven't seen this kind of excitement for some time!
bamboo2
06/3/2015
07:58
I agree, I agree I agree 😜
rayrac
06/3/2015
07:54
I think this kind of RNS could attract the attention of the KCI's of this world.
bamboo2
06/3/2015
07:52
Our patience is about to be rewarded! Just cresting the hill, the view is about to improve...
rayrac
05/3/2015
12:54
Hmmm - one swallow does not make a summer. One operation is not a gurantee of success. This ist the sort of RNS that a pharma co would send out. I hope our standards are not that low.

Lets see one that says sales are booming and the goods are flying out of the factory.

swiss paul
05/3/2015
11:26
Well, there is some newsflow ! Early days for this Orthopure XM trial but good news all the same.
Good to see the product will be launched in the EU in 2016 and the demand that is there for it.
Might explain the little flurry of activity in the share price yesterday !

luminoso
04/3/2015
17:55
Andrew, all good points.

The chart showed a small head and shoulders that is now complete.

Newsflow should get going again soon, with some interim info from the US clinical trial, and hopefully some further confirmation of the start of commercial activities.

bamboo2
04/3/2015
17:37
The price has once again got to very interesting levels. Being a small company the share price will fluctuate, but at its current level, it is temping to buy more. The product is excellent, barriers to entry extremely high, and the demand will never be less than very good. I am showing a substantial profit thus far, and buying more may make my portfolio a tad TRX-heavy, but it would likely be worth doing.
andrewbaker
04/3/2015
16:01
Hmmm. Not entirely convinced that 284k was a sale.
luminoso
04/3/2015
15:32
Some interesting price action these last few minutes. Sharp fall and mostly buys recorded. Was it just walked down to accomodate someone ?
luminoso
03/3/2015
08:27
bamboo - a company needs independent NEDs to stand up for the rights of the independent shareholders like us.
If they haven't got any, there's no NEDs to agree the correct price for a takeover if they're all doing what is good for their employer rather than the shareholders as a whole.
The Company agree with me too "In accordance with the Company's strategy to evolve the composition of the Board, the search for an independent Non-Executive Director is well underway."

igbertsponk
Chat Pages: Latest  338  337  336  335  334  333  332  331  330  329  328  327  Older

Your Recent History

Delayed Upgrade Clock